Literature DB >> 31173413

Extracorporeal membrane oxygenation support following liver transplantation-A case series.

Naeem Goussous1, Hashem Akbar1, John C LaMattina1, Steven I Hanish2, Rolf N Barth1, David A Bruno1.   

Abstract

BACKGROUND: Postoperative severe cardiopulmonary failure carries a high rate of mortality. Extracorporeal membrane oxygenation (ECMO) can be used as a salvage therapy when conventional therapies fail.
METHODS: We retrospectively reviewed our experience with ECMO support in the early postoperative period after liver transplant between September 2011 and May 2016.
RESULTS: Out of 537 liver transplants performed at our institution, seven patients required ECMO support with a median age of 52 and a median MELD score of 28. Veno-venous ECMO was used in four patients with severe respiratory failure while the rest required veno-arterial ECMO for circulatory failure. The median time from transplant to cannulation was 3 days with a median duration of ECMO support of 7 days. All patients except one were successfully decannulated. The median hospital length of stay was 58 days with an in-hospital mortality of 28.6%.
CONCLUSION: Extracorporeal membrane oxygenation can be considered a viable rescue therapy in the setting of severe postoperative cardiopulmonary failure. Extracorporeal membrane oxygenation therapy was successful in saving patients who were otherwise unsalvageable.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ECMO; cardiopulmonary failure; liver failure

Mesh:

Year:  2019        PMID: 31173413     DOI: 10.1111/ctr.13628

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  1 in total

Review 1.  The evolving role of ECMO in liver transplantation.

Authors:  Rachel Hogen; Ashraf H Sedra; Arash Motamed; Juliet Emamaullee
Journal:  Curr Opin Organ Transplant       Date:  2021-06-01       Impact factor: 2.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.